Fuat Demirkıran

11PUBLICATIONS
91CO-AUTHORS
Predictive and prognostic markersPsychological methodology, design and analysisCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 24, 2025
Comparison of oncologic outcome of preoveratively presumed low-risk endometrial cancer patients who underwent only bilateral pelvic sentinel lymph node (SLN) removal and those who underwent pelvic lymphadenectomy in addition to bilateral pelvic SLN removal: Turkish Gynecologic Oncology Group (TRSGO-SLN-009).

Tugan Bese, Sait Sukru Cebi, Salih Taskin

|Aug 29, 2025
The relationship between histopathological data and molecular alterations with oncological outcomes in endometrioid-type endometrial cancers and a novel POLE mutation.

Elif Aksahin, Fuat Demirkiran, Tugan Bese

|May 20, 2024
Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.

Fatma Ferda Verit, Tugan Bese, Fuat Demirkiran

|Feb 07, 2023
Juvenile granulosa cell tumor: 20 years' experience of a Tertiary Center.

Kübra Hamzaoğlu Canbolat, Elifnur Biçer, Şennur İlvan

|Jun 06, 2022
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA-MONO/GOG-3020/ENGOT-ov45).

Bradley J Monk, Christine Parkinson, Myong Cheol Lim

|Dec 13, 2021
Could the Long-Term Oncological Safety of Laparoscopic Surgery in Low-Risk Endometrial Cancer also Be Valid for the High-Intermediate- and High-Risk Patients? A Multi-Center Turkish Gynecologic Oncology Group Study Conducted with 2745 Endometrial Cancer Cases. (TRSGO-End-001).

Mehmet Ali Vardar, Ahmet Baris Guzel, Salih Taskin

Pageof 2

Frequent Collaborators

8 joint publications

Tugan Bese

6 joint publications

Macit Arvas

5 joint publications

Ilker Kahramanoglu

2 joint publications

Ghanim Khatib